This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

MorphoSys has a total shareholder equity of €-261.7M and total debt of €1.7B, which brings its debt-to-equity ratio to -658%. Its total assets and total liabilities are €1.8B and €2.1B respectively.

Anahtar bilgiler

-658.0%

Borç/özkaynak oranı

€1.72b

Borç

Faiz karşılama oranın/a
Nakit€630.77m
Eşitlik-€261.67m
Toplam yükümlülükler€2.09b
Toplam varlıklar€1.83b

Son finansal sağlık güncellemeleri

Recent updates

MorphoSys: Hold Rating Until The Novartis Deal Closes

May 01

Novartis And MorphoSys Are A Perfect Match

Feb 06

MorphoSys: Positive Pelabresib Data Finally Unlocking Upside

Jan 18

MorphoSys updates Q2 & FY22 guidance below prior provided levels

Jul 26

MorphoSys May Not Recover From Adventurous Constellation Buyout

May 04

Sierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And Incyte

Jan 28

Incyte and MorphoSys presents new three-year data for blood cancer therapy

Jun 04

MorphoSys reports Q1 results

May 05

MorphoSys AG appoints Sangamo 's Sung Lee as new CFO

Jan 06

MorphoSys AG (MOR) Investor Presentation - Slideshow

Dec 08

MorphoSys AG 2020 Q3 - Results - Earnings Call Presentation

Nov 22

MorphoSys reports Q3 results

Nov 11

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MOR has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: MOR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: MOR has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: MOR has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.7% each year


Sağlıklı şirketleri keşfedin